SPONSOR
Fundación GECP
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Non-small Cell Lung Cancer Stage IIIKRAS P.G12CPDL1 Gene MutationSmall Cell Lung Cancer Extensive Stage
NCT05398094 Phase 2
Recruiting
Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy
Non-small Cell Lung Cancer Stage III
NCT06634199
Recruiting
Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients
Non-small Cell Lung Cancer Stage III
NCT05384015 Phase 2
Recruiting
Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer
Small Cell Lung Cancer Extensive Stage